Orthostatic hypotension refers to a form of low blood pressure that occurs when standing up from sitting or lying down. Some key symptoms include dizziness, weakness, blurred vision, and fainting. It occurs due to abnormalities in the autonomic nervous system that help regulate blood pressure. The condition is commonly seen in the elderly population as well as in people suffering from Parkinson's disease, diabetes, and certain other medical conditions that damage the autonomic nervous system. Orthostatic hypotension can severely impact mobility and quality of life if left untreated.

The orthostatic hypotension market is estimated to be valued at USD 1.93 Bn in 2024 and is expected to reach USD 3.15 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

The rising geriatric population worldwide vulnerable to orthostatic hypotension due to age-related decline in autonomic function is a key growth driver for the market. It is estimated that over 16% of the global population will be aged 65 years and above by 2050. This growing senior population base will drive the demand for orthostatic hypotension drugs over the coming years. Poor lifestyle factors coupled with the increasing prevalence of chronic diseases damaging the autonomic nervous system will further propel the Orthostatic Hypotension Market Growth.

Get More Insights On- Orthostatic Hypotension Market

Get This Report in Japanese Language: 起立性低血圧市場

Get This Report in Korean Language: 기립성 저혈압 시장